Megan Boston
CIK: 0001808923
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTC
Benitec Biopharma Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Boston Megan
Boston Megan (SEC CIK 0001808923) files insider reports with the SEC as Executive Director of Benitec Biopharma Inc. (BNTC).
Signal8 holds 2 ownership filings by Boston Megan, all Form 4s, filed between Dec 11, 2024 and Nov 20, 2025. Those filings report 2 transactions, from Dec 9, 2024 to Nov 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Boston Megan's filings is in HAYWARD, CA.
Recent filings by Boston Megan
Other insiders filing for Benitec Biopharma Inc. (BNTC)
- Friedman David Matthew, Director
- Mates Sharon, Director
- MONTANOVA CAPITAL, LLC, Director
- Mehta Kishan, Director
- Smith Edward F, Director
- Francis Peter, Director